Cystoid macular edema in aphakia and pseudophakia after use of prostaglandin analogs

Seminars in Ophthalmology

Volumn 17, Issue 3-4, 2002, Pages 181-186

  Halpern, D Lynn ^a,b   Pasquale, Louis R ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b NONE   (United States)

Author keywords

Aphakia; Cystoid macular edema; Highrisk eyes; Latanoprost; Prostaglandin analogs; Pseudophakia

Indexed keywords

ANTIINFLAMMATORY AGENT; BENZALKONIUM CHLORIDE; BIMATOPROST; BRIMONIDINE; CHLORBUTOL; DICLOFENAC; FLUOROMETHOLONE; KETOROLAC; LATANOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PRESERVATIVE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID; TIMOLOL; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

ADULT; ANTIHYPERTENSIVE ACTIVITY; APHAKIA; BLOOD RETINA BARRIER; CAPSULOTOMY; CASE REPORT; DRUG MECHANISM; EVIDENCE BASED MEDICINE; HIGH RISK PATIENT; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA MACULA CYSTOID EDEMA; REVIEW;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; APHAKIA, POSTCATARACT; BLOOD-RETINAL BARRIER; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; PROSTAGLANDINS F, SYNTHETIC; PSEUDOPHAKIA; VISUAL ACUITY;

EID: 0036770757     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.17.3.181.14789     Document Type: Review

References (25)

1. Woodward DF, Regan JW, Lake S, Ocklind A. The molecular biology and ocular distribution of prostanoid receptors. Surv Ophthalmol. 1997;41 Suppl 2:S15-S21.
2. Crawford K, Kaufman PL. Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha. Arch Ophthalmol. 1987;105(8):1112-1116.
3. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol. 1997;41 Suppl 2:S53-S59.
4. Yousufzai SY, Ye Z, Abdel-Latif AA. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res. 1996;63(3):305-310.
5. Weinreb RN, Lindsey JD. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci. 2002;43(3):716-722.
6. Rowe JA, Hattenhauer MG, Herman DC. Adverse side effects associated with latanoprost. Am J Ophthalmol. 1997;124(5):683-685.
7. Ayyala RS, Cruz DA, Margo CE et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol. 1998;126(4):602-604.
8. Avakian A, Renier SA, Butler PJ. Adverse effects of latanoprost on patients with medically resistant glaucoma. Arch Ophthalmol. 1998;116(5):679-680.
9. Heier JS, Steinert RF, Frederick AR, Jr. Cystoid macular edema associated with latanoprost use. Arch Ophthalmol. 1998;116(5):680-682.
10. Callanan D, Fellman RL, Savage JA. Latanoprost-associated cystoid macular edema. Am J Ophthalmol. 1998;126(1):134-135.
11. Thorne JE, Maguire AM, Lanciano R. CME and anterior uveitis with latanoprost use. Ophthalmology. 1998;105 (11):1981-1983.
12. Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology. 1998;105(2):263-8.
13. Wardrop DR, Wishart PK. Latanoprost and cystoid macular oedema in a pseudophake. Br J Ophthalmol. 1998; 82(7):843-844.
14. Gaddie IB, Bennett DW. Cystoid macular edema associated with the use of latanoprost. J Am Optom Assoc. 1998; 69(2):122-128.
15. Moroi SE, Gottfredsdottir MS, Schteingart MT et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology. 1999;106(5):1024-1029.
16. Lima MC, Paranhos A, Jr., Salim S et al. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J Glaucoma. 2000;9(4):317-321.
17. Schumer RA, Camras CB, Mandahl AK. Latanoprost and cystoid macular edema: is there a causal relation? Curr Opin Ophthalmol. 2000;11(2):94-100.
18. Wand M, Gaudio AR. Cystoid molecular edema associated with ocular hypotensive lipids. Am J Ophthalmol. 2002; 133(3):403-405.
19. Wand M, Gaudio AR, Shields MB. Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes. J Cataract Refract Surg. 2001;27(9):1397-1401.
20. Furuichi M, Chiba T, Abe K et al. Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier. J Glaucoma. 2001;10(3):233-236.
21. Hoyng PF, Rulo AH, Greve EL, Astin M, Gjotterberg M. Fluorescein angiographic evaluation of the effect of latanoprost treatment on blood-retinal barrier integrity: a review of studies conducted on pseudophakic glaucoma patients and on phakic and aphakic monkeys. Surv Ophthalmol. 1997;41 Suppl 2:S83-S88.
22. Miyake K, Ota I, Maekubo K, Ichihashi S, Miyake S. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117(1):34-40.
23. Miyake K, Ota I, Ibaraki N et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol. 2001;119(3):387-394.
24. Masferrer JL, Kulkarni PS. Cyclooxycygenase-2 inhibitors: a new approach to the therapy of ocular inflammation. Surv Ophthalmol. 1997;41 Suppl 2:S35-S40.
25. Blair NP, Kim SH, Friedlander SM. Cystoid macular edema after ocular surgery. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. 2nd ed. Vol. 3. Philadelphia: W.B. Saunders Company; 2000: 2080-2088.